论文部分内容阅读
Eltrombopag是由葛兰素史克公司开发的一个小分子、非肽类血小板生成素(TPO)受体激动剂。商品名为RevoladePOM和Promacta,化学名为33’-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazino}-2’-hydroxy biphenyl-3-carboxylic acid,分子式为C25H22N4O4,相对分子质量442.47,CAS号496775-61-2,结构见图1。
Eltrombopag is a small molecule non-peptide thrombopoietin (TPO) receptor agonist developed by GlaxoSmithKline. Revolade POM and Promacta under the chemical name of 33 ’- {2- [1- (3,4-dimethylphenyl) -3-methyl-5- oxo-4,5-dihydro-1H-pyrazol-4-ylidene] hydrazino} -2’-hydroxy biphenyl-3-carboxylic acid, molecular formula C25H22N4O4, relative molecular mass 442.47, CAS number 496775-61-2, the structure shown in Figure 1.